Project Grant HT94252510624
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$873K
Federal Agency
Defense Health Agency
Awardee
Luna Labs USA LLC (M6JVSYRQRYM9)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $413,400 Project Grant to Children's Home Healthcare of Cincinnati, OH through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2023 exploring the role of endoplasmic reticulum stress and systemic inflammation in blunt traumatic brain injury-induced optic nerve damage. The Military Medical Research and Development program supports basic, applied, and...
The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health care...
The Department of the Army Medical Command awarded a $430,513 Project Grant to The Leland Stanford Junior University (Stanford University) on March 1, 2025 to support research under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund a 2-year research project to "UNDERSTAND HOW VASCULAR ENDOTHELIAL CELLS REGULATE FIBROBLAST FUNCTIONS IN PANCREATITIS." This research initiative aims to advance biomedical understanding and treatment of...
The Department of the Army Medical Command awarded a $325,142 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Onward Medical Inc. in Boston, MA. The grant, with a performance period from Sep 1, 2025 to Aug 31, 2028, will fund the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. This research aims to transform healthcare for military service members and the broader public by...
The Department of the Army Medical Command awarded Yale University a $738,509 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into "THE ROLE OF TLR7/8-ACTIVATING MICRORNAS IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME" from September 30, 2021 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The U.S. Department of the Army Medical Command awarded a $670,917 Project Grant (CFDA 12.420 - Military Medical Research and Development) to Yale University on June 15, 2025, with a completion date of June 14, 2027. The grant supports advanced biomedical research focused on exploiting METTL3 inhibition-induced dysregulation of DNA repair in the treatment of leukemia. The research aims to transform healthcare for military service members and the broader public through innovative and impactful...
The Department of the Army Medical Command awarded Duke University a $472,184 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2024 to exploit ferropotosis for the treatment of RB1-deficient lethal prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...